Developer docs
API playgroundTry for free, no card

Search company profiles

Vertex Ventures China

Full company profile

uuid0000b1x

Namestring
Vertex Ventures China
Legal namestring
Vertex Ventures China
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Vertex Ventures China is the China-focused early-stage venture capital arm of Singapore-based Vertex Ventures, itself backed by sovereign wealth fund Temasek Holdings. Founded in 2009 and headquartered in Beijing with additional offices in Shanghai, Shenzhen, and Singapore, the firm manages approximately RMB 20 billion in combined assets across multiple USD and RMB funds. Vertex China invests in high-growth innovative enterprises in mainland China across two primary verticals: innovative technology (robotics, AI, semiconductor chips, advanced manufacturing, carbon neutrality, new materials, and commercial aerospace) and biomedicine (including medical devices). The firm has built a portfolio of 115+ companies, including 20+ unicorns, with 16 successful exits such as Mobike (acquired by Meituan), AnHeart (acquired by Nuvation Bio), and public listings including Horizon Robotics (9660.HK), Geek+ (2590.HK), Harbour BioMed (02142.HK), and SES AI (NYSE: SES).

The firm's core "product" is capital and value-added services delivered to early-stage founders, packaged with access to the broader Vertex global network spanning Israel, Japan, Southeast Asia, India, and the US. Revenue is generated through traditional VC economics — management fees on committed capital (typically 2%) and carried interest on profitable exits (typically 20% above hurdle rates) — with the dual-currency fund structure providing deployment flexibility across regulatory environments. Deal sourcing is network-driven, leveraging the Vertex global network, the Temasek ecosystem, portfolio company referrals, and participation in industry conferences such as the 36Kr WAVES New Wave 2025 Conference. The founding team has maintained 15+ years of continuity, with Managing Partners Tay Chee Chong and Xia Zhijin leading investment strategy, supported by Executive Partner Li Wei and Partner Yuan Jianwei.

Vertex China's competitive positioning rests on three structural advantages: the Temasek sovereign backing providing institutional credibility and co-investment capacity, the global Vertex network offering cross-border expansion pathways for portfolio companies, and a senior team with deep sector relationships built over more than a decade in China's VC ecosystem. The firm's recent activity — including the angel round lead in PureblueAI (an AI marketing technology company) in 2026 alongside co-investors 36Kr, Inno Fund, and Yicun Songling — signals continued active deployment and selective expansion into applied AI investment themes.

Short descriptiontext

Vertex Ventures China is an early-stage venture capital firm investing in China's high-growth innovative technology and biomedicine startups, backed by Temasek Holdings and operating within the global Vertex Ventures network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBeijing, China
HQ citystring
Beijing
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, early-stage equity funding, technology startup investment, biomedicine venture capital, growth capital financing
Industry1 code
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • All Other Financial Investment Activities52399
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles1 record
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Vertex Ventures China (祥峰中国) is an early-stage venture capital firm that deploys capital from multiple USD and RMB funds into high-growth technology and biomedicine startups across mainland China. The firm invests across sectors including robotics, artificial intelligence, semiconductor chips, advanced manufacturing, carbon neutrality, new materials, biomedicine, medical devices, and commercial aerospace, and complements capital with value-added services and access to the broader Vertex global network. Vertex China operates as part of the Vertex Ventures network backed by Temasek Holdings of Singapore.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Vertex Ventures China (祥峰投资) is a venture capital firm backed by Temasek Holdings of Singapore. It does not offer technology products or services to external customers. The firm operates multiple US dollar and RMB funds with combined assets under management of approximately RMB 20 billion (200亿元), focusing on early-stage investments in innovative technology and biomedicine sectors. Its core activities include identifying, funding, and supporting high-growth startups in robotics, artificial intelligence, semiconductor chips, advanced manufacturing, carbon neutrality, new materials, biomedicine, medical devices, and commercial aerospace.

Product and service2 records
1USD Venture Capital Funds
CategoryVenture Capital Fund (USD)
Description

USD-denominated early-stage venture capital funds that deploy equity into high-growth Chinese startups in robotics, AI, semiconductor chips, advanced manufacturing, biomedicine, medical devices, and other innovation sectors. The funds are targeted at institutional and accredited limited partners seeking exposure to China's early-stage innovation economy.

2RMB Venture Capital Funds
CategoryVenture Capital Fund (RMB)
Description

RMB-denominated early-stage venture capital funds that deploy equity into high-growth Chinese startups, enabling the firm to invest across different market conditions and accommodate domestic Chinese limited partners. Combined with the USD funds, total AUM is approximately RMB 20 billion.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment216 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vertex Ventures China

Venture Capitalvertexventures.cn

Vertex Ventures China is an early-stage venture capital firm investing in China's high-growth innovative technology and biomedicine startups, backed by Temasek Holdings and operating within the global Vertex Ventures network.

What Vertex Ventures China does

Vertex Ventures China is the China-focused early-stage venture capital arm of Singapore-based Vertex Ventures, itself backed by sovereign wealth fund Temasek Holdings. Founded in 2009 and headquartered in Beijing with additional offices in Shanghai, Shenzhen, and Singapore, the firm manages approximately RMB 20 billion in combined assets across multiple USD and RMB funds. Vertex China invests in high-growth innovative enterprises in mainland China across two primary verticals: innovative technology (robotics, AI, semiconductor chips, advanced manufacturing, carbon neutrality, new materials, and commercial aerospace) and biomedicine (including medical devices). The firm has built a portfolio of 115+ companies, including 20+ unicorns, with 16 successful exits such as Mobike (acquired by Meituan), AnHeart (acquired by Nuvation Bio), and public listings including Horizon Robotics (9660.HK), Geek+ (2590.HK), Harbour BioMed (02142.HK), and SES AI (NYSE: SES).

The firm's core "product" is capital and value-added services delivered to early-stage founders, packaged with access to the broader Vertex global network spanning Israel, Japan, Southeast Asia, India, and the US. Revenue is generated through traditional VC economics — management fees on committed capital (typically 2%) and carried interest on profitable exits (typically 20% above hurdle rates) — with the dual-currency fund structure providing deployment flexibility across regulatory environments. Deal sourcing is network-driven, leveraging the Vertex global network, the Temasek ecosystem, portfolio company referrals, and participation in industry conferences such as the 36Kr WAVES New Wave 2025 Conference. The founding team has maintained 15+ years of continuity, with Managing Partners Tay Chee Chong and Xia Zhijin leading investment strategy, supported by Executive Partner Li Wei and Partner Yuan Jianwei.

Vertex China's competitive positioning rests on three structural advantages: the Temasek sovereign backing providing institutional credibility and co-investment capacity, the global Vertex network offering cross-border expansion pathways for portfolio companies, and a senior team with deep sector relationships built over more than a decade in China's VC ecosystem. The firm's recent activity — including the angel round lead in PureblueAI (an AI marketing technology company) in 2026 alongside co-investors 36Kr, Inno Fund, and Yicun Songling — signals continued active deployment and selective expansion into applied AI investment themes.

Vertex Ventures China firmographics

Firmographics
Name
Vertex Ventures China
Legal name
Vertex Ventures China
Website
https://vertexventures.cn
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
1–10 employees
Short description
Vertex Ventures China is an early-stage venture capital firm investing in China's high-growth innovative technology and biomedicine startups, backed by Temasek Holdings and operating within the global Vertex Ventures network.
Ownership category
akta.pro rank

Vertex Ventures China industry classification

Industry
Product category
Venture Capital
NAICS
Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)

Keywords

  • Venture capital investing
  • Early-stage equity funding
  • Technology startup investment
  • Biomedicine venture capital
  • Growth capital financing

Where Vertex Ventures China is headquartered

Location

Headquarters

HQ city
Beijing
HQ country
China
HQ region
Asia

Offices4 records

Markets served

Vertex Ventures China business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels3 records

Vertex Ventures China product offering

Product offering

Core offering

Vertex Ventures China (祥峰中国) is an early-stage venture capital firm that deploys capital from multiple USD and RMB funds into high-growth technology and biomedicine startups across mainland China. The firm invests across sectors including robotics, artificial intelligence, semiconductor chips, advanced manufacturing, carbon neutrality, new materials, biomedicine, medical devices, and commercial aerospace, and complements capital with value-added services and access to the broader Vertex global network. Vertex China operates as part of the Vertex Ventures network backed by Temasek Holdings of Singapore.

Product overview

Vertex Ventures China (祥峰投资) is a venture capital firm backed by Temasek Holdings of Singapore. It does not offer technology products or services to external customers. The firm operates multiple US dollar and RMB funds with combined assets under management of approximately RMB 20 billion (200亿元), focusing on early-stage investments in innovative technology and biomedicine sectors. Its core activities include identifying, funding, and supporting high-growth startups in robotics, artificial intelligence, semiconductor chips, advanced manufacturing, carbon neutrality, new materials, biomedicine, medical devices, and commercial aerospace.

Differentiator

Problem solved

Functional benefit

Products and services

  • USD Venture Capital Funds USD-denominated early-stage venture capital funds that deploy equity into high-growth Chinese startups in robotics, AI, semiconductor chips, advanced manufacturing, biomedicine, medical devices, and other innovation sectors. The funds are targeted at institutional and accredited limited partners seeking exposure to China's early-stage innovation economy.
  • RMB Venture Capital Funds RMB-denominated early-stage venture capital funds that deploy equity into high-growth Chinese startups, enabling the firm to invest across different market conditions and accommodate domestic Chinese limited partners. Combined with the USD funds, total AUM is approximately RMB 20 billion.

Companies that use Vertex Ventures China

Customer profile

Segments2 records

Ideal customer profiles2 records

Vertex Ventures China technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Vertex Ventures China partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves6 records

Expansion highlights4 records

Vertex Ventures China competitors and assessment

Company assessment

Market position

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Vertex Ventures China social profiles

Digital presence

Vertex Ventures China financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vertex Ventures China leadership team

Management profile

Number of profiles

Profiles6 records

Vertex Ventures China funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vertex Ventures China M&A and investment

M&A and investment

M&A

Investments216 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vertex Ventures China

What does Vertex Ventures China do?

Vertex Ventures China (祥峰中国) is an early-stage venture capital firm that deploys capital from multiple USD and RMB funds into high-growth technology and biomedicine startups across mainland China. The firm invests across sectors including robotics, artificial intelligence, semiconductor chips, advanced manufacturing, carbon neutrality, new materials, biomedicine, medical devices, and commercial aerospace, and complements capital with value-added services and access to the broader Vertex global network. Vertex China operates as part of the Vertex Ventures network backed by Temasek Holdings of Singapore.

Is Vertex Ventures China a public or private company?

Vertex Ventures China is a private company. It is classified as corporate owned and is currently operating.

When was Vertex Ventures China founded?

Vertex Ventures China was founded in 2009. It employs 1 to 10 people.

Where is Vertex Ventures China based?

Vertex Ventures China is headquartered in Beijing, China, in the Asia region.

Does Vertex Ventures China have an API?

No public API is recorded for Vertex Ventures China.

What industry is Vertex Ventures China in?

Vertex Ventures China's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Fastdata极数Shenzhen Full-Stack Embodied Intelligent Model Company Chao Wei Power Completes Over 500 Million Angel + Round Series Financing – Fastdata Extreme NumberChao Wei Power, a full-stack embodied intelligent model company, completed a series of angel+ round financing exceeding 500 million yuan. The round was led by Singapore's Temasek Holdings' VC institutions, with Huaxing Capital as exclusive financial advisor. Proceeds will accelerate iteration of 'data-model-ontology' and productization of embodied intelligence.DoNews巢匠科技完成数亿元天使轮系列融资- DoNews快讯Nestworks, a smart desktop-level CNC company, completed hundreds of millions in angel round financing. Leading institutions including Sequoia China, BlueRun Ventures, Zhongding Capital, Xiangfeng Investment, and Yuanjing Capital participated, with Gao Hu Capital as exclusive financial advisor. The funds will support R&D, AI software iteration, creator ecosystem, and global expansion.Fastdata极数Chengdu brain-computer interface developer Wabo Technology announces the completion of a new round of financing - FastdataWabo Technology, a brain-computer interface developer, announced completion of a new financing round. The round was jointly invested by Sequoia Capital, Hongtai Fund, Chengdu Future Industry Fund, and Huifengda Capital.ChinaventureFirst release | Shanghai and Beijing state-owned assets join forces to bet on an AI4M companyDeepMind completed a nearly 1 billion yuan Series A financing, led by Shanghai's Foton Capital and Beijing's Shunxi Fund. The company, focused on AI for materials, also received oversubscription from existing investors. The investment signals state-owned backing for AI-driven scientific innovation.ChinaventureDeep principle has completed nearly 1 billion yuan in Series A financing.Deep Principle, a global leader in AI for Materials, completed Series A financing of nearly 1 billion yuan. The round was led by Foton Capital, with follow-on investments from Huakong Fund, Kangjun Capital, and others, and over half of existing shareholders increased their stakes.Fastdata极数Scientific research in the field of AI-driven material chemistry innovation in Hangzhou has completed nearly 1 billion yuan in Series A financing - Fastdata.Deep Principle, an AI-driven material chemistry company in Hangzhou, completed nearly 1 billion yuan in Series A financing led by Foton Capital. The funding will support its AI, quantum chemistry, and high-throughput experimental workflow for accelerating material discovery and optimization.ChinaventureChinese Investor Podcast 'From Hammer to Pull' (June 2026 Edition)Chinese venture capital institutions are increasingly producing video podcasts, with production costs ranging from 20,000 to 50,000 yuan per episode. The June 2026 edition of the 'Chinese Investors Podcast' list focuses on video podcasts, following industry trends and Silicon Valley's emphasis on aesthetics as a profit tool.36kr重磅!「PureblueAI清蓝」获数千万元天使轮融资,首推AI口碑营销数字员工PureblueAI Qinglan completed a tens-of-millions RMB angel round led by Vertex China, with participation from 36Kr and existing investors. The funds will support product development and ecosystem expansion. The company launched its AI reputation marketing digital employee Mark, built on its GEO technology.MgcjIf Chuang Technology receives tens of millions of dollars in Pre-A round financing, it will accelerate the layout of low-speed robot research and development.Ruochuang Technology has completed a Pre-A round financing, raising tens of millions of dollars from investment firms Matter Venture Partners and Vertex Ventures. The funding will be used to accelerate R&D and expand market development in the low-speed robotics and smart hardware sector. The successful financing round represents a vote of confidence from investors in the company's technological capabilities and commercial potential amid growing demand for smart manufacturing and IoT applications.